Woman Knits for Cancer
"A BLACKWOOD woman knitted more than 20,000 toy chicks to raise funds for the Velindre Hospital.
Bev Parry, 55 of Pontllanfraith, started knitting the fluffy toys 15 years ago after seeing an advert about the Chick Knit Appeal for the Cardiff hospital.
Now Mrs Parry knits every spare minute she has and has raised more than £20,000 through her work.
She is now calling on others to help her knit 60,000 more chicks over the next year to help bring the total amount raised through the appeal to £1million.
Mrs Parry said: “I used to work in a doctor’s surgery and saw a lot of patients with cancer and wanted to help."
Read More: http://www.southwalesargus.co.uk/news/8487856.Blackwood_woman_knits_20_0...
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
